5QNU
| |
5QOA
| |
5QKF
| |
5QKY
| |
5QLA
| |
5QLU
| |
5QMB
| |
5QMR
| |
5QN6
| |
5QNO
| |
5QO4
| |
5QMF
| |
5QMV
| |
5QNC
| |
5QNR
| |
5QO5
| |
5QMI
| |
5QN0
| |
5QNI
| |
5QNY
| |
5QOF
| |
5QND
| |
5QNT
| |
5QO9
| |
6MAQ
| F9 Pilus Adhesin FmlH Lectin Domain from E. coli UTI89 in Complex with Galactoside 2'-{[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-nitro-[1,1'-biphenyl]-3-carboxylic acid | Descriptor: | 2'-{[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy}-5-nitro[1,1'-biphenyl]-3-carboxylic acid, Fimbrial adhesin FmlD, GLYCEROL | Authors: | Klein, R.D, Hultgren, S.J. | Deposit date: | 2018-08-28 | Release date: | 2019-09-04 | Last modified: | 2023-12-13 | Method: | X-RAY DIFFRACTION (1.31 Å) | Cite: | Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design. J.Med.Chem., 62, 2019
|
|